Cancer/Radiothérapie Journal Citation Rate 2026

ISSN 1278-3218 eISSN 1769-6658 Elsevier BV FR

Q3 Quartile

About Cancer/Radiothérapie
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cancer/Radiothérapie (C) is a peer-reviewed academic journal covering Advanced Radiotherapy Techniques and Brain Metastases and Treatment, published by Elsevier BV in FR, catalogued under ISSN 1278-3218 (e-ISSN 1769-6658). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.14 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$2190 USD). OpenAlex records 6,130 works and 28,000 citations, with an h-index of 53.

Cancer/Radiothérapie Citation Rate 2026 — In Context

Cancer/Radiothérapie has a 2025 2-Year Citation Rate (OpenAlex) of 1.14, placing it in the Q3 quartile within the Advanced Radiotherapy Techniques research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Cancer/Radiothérapie operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Cancer/Radiothérapie should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer/Radiothérapie against similar journals in the field, use our journal comparison tool.

Submission Tips for Cancer/Radiothérapie
  • Budget $2190 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Advanced Radiotherapy Techniques, Brain Metastases and Treatment, Head and Neck Cancer Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer/Radiothérapie Compares
Citation Rate vs Field Avg
-22%
Field avg: 1.45
APC vs Field Avg
-35%
Field avg: $3379

Compared against 33 journals in the same research areas.

ISSN (Print) 1278-3218
ISSN (Online) 1769-6658
Publisher Elsevier BV
Country France
APC / Cost $2190 USD
h-index 53
Total Works 6,138
Total Citations 28,175
2-yr Mean Citedness 1.49 (OpenAlex)
In-depth profile & metrics

Cancer/Radiothérapie is published by Elsevier BV and based in France. It runs on a subscription or hybrid model with an article-processing charge of USD 2190.

In our subject taxonomy, Cancer/Radiothérapie is classified under Advanced Radiotherapy Techniques, Brain Metastases and Treatment, Head and Neck Cancer Studies and Lung Cancer Diagnosis and Treatment.

Cancer/Radiothérapie is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 6,138 works that have together drawn 28,175 citations, giving the journal an h-index of 53; its most recent citation rate stands at 1.137; OpenAlex puts its two-year mean citedness at 1.49.

Research Areas
Links
Frequently Asked Questions about Cancer/Radiothérapie

Cancer/Radiothérapie does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.137 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Cancer/Radiothérapie is not an open access journal.

The Article Processing Charge (APC) for Cancer/Radiothérapie is $2190 USD.

Cancer/Radiothérapie is published by Elsevier BV.

Cancer/Radiothérapie shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Cancer/Radiothérapie is 1278-3218. Its electronic ISSN (eISSN) is 1769-6658.

Cancer/Radiothérapie sits in the Q3 quartile based on its latest impact factor of 1.14, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.137
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.137 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 114 139
2024 101 229
2023 125 349
2022 105 316
2021 232 1,804
2020 193 1,018
2019 268 806
2018 254 913
2017 276 820
2016 351 1,639
2015 296 931
2014 293 954
Journal at a Glance
6,138
Total Works
28,175
Total Citations
53
h-index
1.49
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Cancer/Radiothérapie most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Advanced Radiotherapy Techniques
Physics and Astronomy
1,397 works
603 works
494 works
Breast Cancer Treatment Studies
Biochemistry, Genetics and Molecular Biology
492 works
425 works
377 works

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S171772052

Get weekly updates for Advanced Radiotherapy Techniques journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google